← Back
$KNSA All transactions

Kiniksa Pharmaceuticals International, plc

M

$ Value

$0

Shares

2,558

Price

$0

Filed

Apr 3

Insider

Name

Megna Michael R

Title

CHIEF ACCOUNTING OFFICER

CIK

0001464583

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,557

Footnotes

The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2025 to January 15, 2026. The acquisition of these shares was exempt pursuant to Rule 16b-3(e). | Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. | The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter. | Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee. | Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024. | The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

Filing Info

Accession No.

0001464583-26-000002

Form Type

4

Issuer CIK

0001730430

Megna Michael R's History

Date Ticker Type Value
2026-04-09 KNSA $309K
2026-04-07 KNSA M $4K
2026-04-07 KNSA F $82K
2026-04-07 KNSA M $0
2026-04-01 KNSA M
2026-04-01 KNSA F $154K
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA A $0
2026-04-01 KNSA M $0

Other Insiders at KNSA (90d)

Insider Bought Sold Last
Quart Barry D $345K 2026-04-06
Megna Michael R
CHIEF ACCOUNTING OFFICER
$309K 2026-04-09
Patel Sanj K
CHAIRMAN & CEO
$364K 2026-04-07
Paolini John F.
CHIEF MEDICAL OFFICER
2026-04-07
Ragosa Mark
CHIEF FINANCIAL OFFICER
2026-04-07
Moat Ross
CHIEF OPERATING OFFICER
$195K 2026-04-09
Tessari Eben
CHIEF STRATEGY OFFICER
2026-04-07